| Product Type: | Mouse monoclonal IgG1, primary antibodies |
|---|---|
| Species reactivity: | Human |
| Applications: | WB, IF-Cell, IHC-P, FC |
| Clonality: | Monoclonal |
| Clone number: | E10-A10 |
| Form: | Liquid |
| Storage condition: | 4℃; -20℃ for long term storage. |
| Storage buffer: | Purified antibody in PBS with 0.05% sodium azide. |
| Concentration: | 2ug/ul |
| Purification: | Protein A affinity purified. |
| Molecular weight: | 69 kDa |
| Isotype: | IgG1 |
| Immunogen: | Recombinant protein |
| Positive control: | Human CD93 recombinant protein, CD93-hIgGFc transfected HEK293 cell lysate, human cervical cancer tissue, Hela, HepG2. |
| Subcellular location: | Membrane. |
| Recommended Dilutions:
WB IF-cell IHC-P FC |
1:500-1:1,000 1:50-1:200 1:50-1:200 1:100-1:200 |
| Uniprot #: | SwissProt: Q9NPY3 Human |
| Alternative names: | C1q receptor 1 C1q/MBL/SPA receptor C1qR C1qR(p) C1qr1 C1QR1_HUMAN C1qRp CD93 CD93 antigen CD93 molecule CDw93 Complement component 1 q subcomponent receptor 1 Complement component C1q receptor dJ737E23.1 ECSM3 Matrix remodeling associated protein 4 Matrix remodelling associated 4 Matrix-remodeling-associated protein 4 MXRA4 |
|
Fig1: Western blot analysis of CD93 on human CD93 recombinant protein using anti-CD93 antibody at 1/1,000 dilution. |
|
Fig2: Western blot analysis of CD93 on HEK293 (1) and CD93-hIgGFc transfected HEK293 (2) cell lysate using anti-CD93 antibody at 1/1,000 dilution. |
|
Fig3: ICC staining CD93 (green) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS. |
|
Fig4: Immunohistochemical analysis of paraffin-embedded human cervical cancer tissue using anti-CD93 antibody. Counter stained with hematoxylin. |
|
Fig5: Flow cytometric analysis of HepG2 cells with CD93 antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red). |